Insider Transactions in Q3 2021 at Cardiovascular Systems Inc (CSII)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 28
2021
|
Jeffrey S. Points Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
778
-0.78%
|
$27,230
$35.38 P/Share
|
|
Aug 28
2021
|
Rhonda J. Robb Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,589
-0.97%
|
$55,615
$35.38 P/Share
|
|
Aug 28
2021
|
Alexander Rosenstein General Counsel & Corp. Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
681
-0.71%
|
$23,835
$35.38 P/Share
|
|
Aug 28
2021
|
Sandra Sedo Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
486
-0.63%
|
$17,010
$35.38 P/Share
|
|
Aug 28
2021
|
Scott R. Ward Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,593
-0.8%
|
$160,755
$35.38 P/Share
|
|
Aug 19
2021
|
Ryan Egeland Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,099
-1.53%
|
$39,564
$36.18 P/Share
|
|
Aug 19
2021
|
Ryan Egeland Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,107
-1.52%
|
-
|
|
Aug 19
2021
|
John M. Hastings VP Manufacturing & Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
925
-1.83%
|
$33,300
$36.18 P/Share
|
|
Aug 19
2021
|
John M. Hastings VP Manufacturing & Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
931
-1.81%
|
-
|
|
Aug 19
2021
|
Jeffrey S. Points Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,680
-4.49%
|
$168,480
$36.18 P/Share
|
|
Aug 19
2021
|
Jeffrey S. Points Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,714
-4.32%
|
-
|
|
Aug 19
2021
|
Rhonda J. Robb Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,560
-5.5%
|
$344,160
$36.18 P/Share
|
|
Aug 19
2021
|
Rhonda J. Robb Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,630
-5.25%
|
-
|
|
Aug 19
2021
|
Alexander Rosenstein General Counsel & Corp. Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,095
-4.09%
|
$147,420
$36.18 P/Share
|
|
Aug 19
2021
|
Alexander Rosenstein General Counsel & Corp. Sec. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,125
-3.96%
|
-
|
|
Aug 19
2021
|
Sandra Sedo Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,925
-3.67%
|
$105,300
$36.18 P/Share
|
|
Aug 19
2021
|
Sandra Sedo Chief Compliance Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,683
-4.42%
|
-
|
|
Aug 19
2021
|
Scott R. Ward Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
27,637
-4.59%
|
$994,932
$36.18 P/Share
|
|
Aug 19
2021
|
Scott R. Ward Chairman and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
27,842
-4.42%
|
-
|
|
Aug 19
2021
|
David Whitescarver VP of Corp. Dev. and IP |
SELL
Payment of exercise price or tax liability
|
Direct |
1,009
-1.7%
|
$36,324
$36.18 P/Share
|
|
Aug 19
2021
|
David Whitescarver VP of Corp. Dev. and IP |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,015
-1.68%
|
-
|
|
Aug 13
2021
|
David Whitescarver VP of Corp. Dev. and IP |
SELL
Payment of exercise price or tax liability
|
Direct |
1,568
-2.54%
|
$56,448
$36.07 P/Share
|
|
Aug 13
2021
|
Scott R. Ward Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,570
-1.65%
|
$380,520
$36.07 P/Share
|
|
Aug 13
2021
|
Sandra Sedo Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,108
-1.31%
|
$39,888
$36.07 P/Share
|
|
Aug 13
2021
|
Alexander Rosenstein General Counsel & Corp. Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,685
-1.59%
|
$60,660
$36.07 P/Share
|
|
Aug 13
2021
|
Rhonda J. Robb Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,316
-1.78%
|
$119,376
$36.07 P/Share
|
|
Aug 13
2021
|
Stephen J. Rempe Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,526
-3.34%
|
$54,936
$36.07 P/Share
|
|
Aug 13
2021
|
Jeffrey S. Points Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,102
-1.89%
|
$75,672
$36.07 P/Share
|
|
Aug 13
2021
|
Ryan Egeland Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,820
-2.44%
|
$65,520
$36.07 P/Share
|
|
Aug 13
2021
|
John M. Hastings VP Manufacturing & Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,436
-2.72%
|
$51,696
$36.07 P/Share
|
|
Aug 09
2021
|
Scott R. Ward Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
132,563
+9.61%
|
-
|
|
Aug 09
2021
|
Jeffrey S. Points Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,407
+12.09%
|
-
|
|
Aug 09
2021
|
Rhonda J. Robb Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,588
+10.06%
|
-
|
|
Aug 09
2021
|
Alexander Rosenstein General Counsel & Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
22,304
+9.77%
|
-
|
|
Aug 09
2021
|
Sandra Sedo Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,339
+9.54%
|
-
|
|
Aug 09
2021
|
Ryan Egeland Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,751
+11.0%
|
-
|
|
Aug 09
2021
|
John M. Hastings VP Manufacturing & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
16,308
+13.99%
|
-
|
|
Aug 09
2021
|
David Whitescarver VP of Corp. Dev. and IP |
BUY
Grant, award, or other acquisition
|
Direct |
15,976
+11.87%
|
-
|
|
Aug 09
2021
|
Stephen J. Rempe Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,714
+15.47%
|
-
|
|
Aug 09
2021
|
Augustine Lawlor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,710
+31.03%
|
-
|
|
Aug 09
2021
|
William E. Cohn Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,447
+19.9%
|
-
|
|
Aug 09
2021
|
Sachin H. Jain Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,447
+50.0%
|
-
|